An Investigational Immuno-therapy Study of Nivolumab or Placebo in Participants With Resected Esophageal or Gastroesophageal Junction Cancer
Clinical trial NCT02743494 · COMPLETED
Trial details
- NCT number
- NCT02743494
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-14
- Primary completion
- 2020-05-12
- Enrollment
- 794
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.